
The Hidden Risk In Cell & Gene Therapy Commercialization
By Jason O’Neill, former CEO, Dendreon Pharmaceuticals Pharmaceutical companies launch new products for two fundamental reasons: new products drive growth and growth drives valuations. But consistent growth has never been harder to come by. The decreasing …